Evonik Industries AG

Informe acción XTRA:EVK

Capitalización de mercado: €8.0b

Evonik Industries Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Evonik Industries han disminuido a una tasa media anual de -31.1%, mientras que en la industria Chemicals los beneficios disminuyeron en un 4.4% anualmente. Los ingresos han ido disminuyendo a una tasa media de 0.8% al año. La rentabilidad financiera de Evonik Industries es de 2%, y sus márgenes netos son de 1.1%.

Información clave

-31.14%

Tasa de crecimiento de los beneficios

-31.11%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 12.41%
Tasa de crecimiento de los ingresos-0.81%
Rentabilidad financiera2.05%
Margen neto1.14%
Próxima actualización de resultados04 Aug 2026

Actualizaciones de resultados anteriores recientes

Artículo de análisis • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...

Recent updates

Artículo de análisis • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
Actualización de narrativa • May 03

EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re Rating

Analysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
Actualización de narrativa • Apr 19

EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating Potential

Analysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
Actualización de narrativa • Apr 03

EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share Performance

Analysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
Actualización de narrativa • Mar 20

EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating Potential

The analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
Actualización de narrativa • Mar 06

EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker Views

Analysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
Actualización de narrativa • Feb 20

EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
Actualización de narrativa • Feb 06

EVK: Weaker Pricing Power Will Drive Lower Future Earnings Expectations

Analysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
Artículo de análisis • Feb 06

Evonik Industries AG (ETR:EVK) Not Flying Under The Radar

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Actualización de narrativa • Jan 23

EVK: Sector Caution And Margin Execution Will Shape Future Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
Actualización de narrativa • Jan 08

EVK: Pricing And Volume Execution Risk Will Pressure Future Earnings

Analysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
Actualización de narrativa • Dec 23

EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside Potential

Evonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
Actualización de narrativa • Dec 09

EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside Potential

The analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
Artículo de análisis • Dec 04

Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Actualización de narrativa • Nov 24

EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform Collaboration

Evonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
Actualización de narrativa • Nov 06

EVK: Resilience And New Partnerships Will Drive Improved Revenue Outlook

Evonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
Artículo de análisis • Oct 30

Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of Investors

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
Actualización de narrativa • Oct 23

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

Evonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
Actualización de narrativa • Oct 09

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
Actualización de narrativa • Sep 25

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
Artículo de análisis • Sep 13

Investors Met With Slowing Returns on Capital At Evonik Industries (ETR:EVK)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Actualización de narrativa • Sep 04

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

With both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
Artículo de análisis • Aug 28

At €16.68, Is It Time To Put Evonik Industries AG (ETR:EVK) On Your Watch List?

Evonik Industries AG ( ETR:EVK ), is not the largest company out there, but it saw significant share price movement...
Artículo de análisis • Jul 11

Investors Still Waiting For A Pull Back In Evonik Industries AG (ETR:EVK)

With a median price-to-sales (or "P/S") ratio of close to 0.7x in the Chemicals industry in Germany, you could be...
Artículo de análisis • Jun 26

Evonik Industries (ETR:EVK) Seems To Use Debt Quite Sensibly

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Artículo de análisis • Jun 11

Evonik Industries' (ETR:EVK) Returns Have Hit A Wall

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
User avatar
Nueva narrativa • Nov 25

Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors

Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.

Desglose de ingresos y gastos

Cómo gana y gasta dinero Evonik Industries. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

XTRA:EVK Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 2613,7191572,160407
31 Dec 2514,0692652,207419
30 Sep 2514,265942,041436
30 Jun 2514,7074232,324437
31 Mar 2515,1382992,374442
31 Dec 2415,1572222,396447
30 Sep 2415,1632292,577424
30 Jun 2415,102-902,310434
31 Mar 2415,058-3562,301431
31 Dec 2315,267-4652,315433
30 Sep 2316,002-6042,371455
30 Jun 2317,109-2952,541455
31 Mar 2317,9952722,560461
31 Dec 2218,4885392,566460
30 Sep 2218,2389262,561471
30 Jun 2217,2319442,457474
31 Mar 2216,0958692,348472
31 Dec 2114,9557482,253464
30 Sep 2114,0787242,186449
30 Jun 2113,1246422,068435
31 Mar 2112,3145462,030428
31 Dec 2012,1994892,022433
30 Sep 2012,2706142,011430
30 Jun 2012,5856172,045433
31 Mar 2013,0656792,070430
31 Dec 1913,1087532,079428
30 Sep 1913,0845062,111437
30 Jun 1913,1996242,139435
31 Mar 1913,3066732,163443
31 Dec 1813,2676862,162437
30 Sep 1813,5808412,238446
30 Jun 1813,7897972,293457
31 Mar 1813,9947882,353467
31 Dec 1714,3837132,409476
30 Sep 1714,0157232,365462
30 Jun 1713,6237182,321455
31 Mar 1713,2626562,273445
31 Dec 1612,7327482,201438
30 Sep 1612,7257582,180448
30 Jun 1612,9267252,154441
31 Mar 1613,1889812,150436
31 Dec 1513,5071,0082,140434
30 Sep 1513,5351,0272,176416
30 Jun 1513,4131,0042,131416

Ingresos de calidad: EVK tiene una única gran pérdida de €320.0M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.1%) de EVK son inferiores a los del año pasado (2%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de EVK han disminuido en un 31.1% al año en los últimos 5 años.

Acelerando crecimiento: EVK ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: EVK tuvo un crecimiento negativo de los beneficios (-47.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-13.5%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de EVK (2%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/26 18:47
Precio de las acciones al final del día2026/05/26 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Evonik Industries AG está cubierta por 31 analistas. 13 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Anil ShenoyBarclays
Andreas HeineBarclays
Sebastian BrayBerenberg